Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Self-Expanding Coronary Sinus Reducer for Treatment of Symptomatic Coronary Microvascular Dysfunction (CMD)

NCT07449325 is registered in ClinicalTrials.gov with VahatiCor, Inc. as lead sponsor.

NCT NCT07449325
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07449325 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Self-Expanding Coronary Sinus Reducer for Treatment of Symptomatic Coronary Microvascular Dysfunction (CMD)
Lead sponsor
VahatiCor, Inc.
Phase
Not applicable
Overall status
Suspended
Start date
April 7, 2026
Completion date
December 31, 2027
Enrollment
30 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

angina pectoris, cardiovascular diseases, heart diseases, microvascular angina, myocardial ischemia, vascular diseases